Orange Book product · Brand (NDA)
ESTRING
ESTRADIOL
At a glance
Apr 26, 1996
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 26, 1996
30 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
ESTRADIOL
Strength
0.0075MG/24HR
Dosage form
INSERT, EXTENDED RELEASE
Route
VAGINAL
TE code
Not listed
Application
NDA 020472
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2018IMVEXXYBrand (NDA)
NDA 208564 · MAYNE PHARMA
- 2014MINIVELLEBrand (NDA)
NDA 203752 · NOVEN
- 2007EVAMISTBrand (NDA)
NDA 022014 · PADAGIS US
- 2007DIVIGELBrand (NDA)
NDA 022038 · VERTICAL PHARMS
- 2006ELESTRINBrand (NDA)
NDA 021813 · VIATRIS
- 2004MENOSTARBrand (NDA)
NDA 021674 · BAYER HLTHCARE
- 2004ESTROGELBrand (NDA)
NDA 021166 · ASCEND THERAPS US
- 2002VIVELLE-DOTBrand (NDA)
NDA 020538 · SANDOZ
- 2002ALORABrand (NDA)
NDA 020655 · ABBVIE
- 2000VIVELLEBrand (NDA)
NDA 020323 · SANDOZ
- 1999ESTRADIOLBrand (NDA)
NDA 021048 · ORTHO MCNEIL PHARM
- 1999CLIMARABrand (NDA)
NDA 020375 · BAYER HLTHCARE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
